Detection of cervical cancer and its precursors by endocervical curettage in 13,115 colposcopically guided biopsy examinations.
OBJECTIVE
Endocervical curettage (ECC) specimens obtained during colposcopy can detect cervical cancer and precursors otherwise missed by biopsy alone, but the procedure can be painful and reduce compliance with needed follow-up. ECC is routinely performed in the Calgary Health Region colposcopy clinics, permitting a look at its real-world utility.


METHODS
We analyzed pathology and colposcopy reports from 2003 to 2007. We calculated the added diagnostic utility of ECC compared with cervical biopsy alone.


RESULTS
ECC increased the diagnostic yield of cervical intraepithelial neoplasia grade 2 or worse (cervical intraepithelial neoplasia [CIN]2+) in 1.01% of 13,115 colposcopically guided biopsy examinations. Therefore, 99 ECC specimens were taken to detect 1 additional CIN2+. ECC detected 5.4% of 2443 CIN2+ subjects otherwise missed by biopsy alone. Utility was greatest among women aged 46 years or older referred after a high-grade cytology.


CONCLUSIONS
ECC is rarely informative when used routinely in colposcopic practice. Older women referred after high-risk cytology benefit most from ECC.
Gage
Julia C
JC
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Boulevard, Rockville, MD 20892, USA. gagej@mail.nih.gov
Duggan
Máire A
MA
Nation
Jill G
JG
Gao
Song
S
Castle
Philip E
PE
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D016009:Chi-Square Distribution; D003127:Colposcopy / Q000379:methods*; D003475:Curettage / Q000379:methods*; D005260:Female; D006801:Humans; D016015:Logistic Models; D008875:Middle Aged; D002583:Uterine Cervical Neoplasms / Q000473:pathology*; D002578:Uterine Cervical Dysplasia / Q000473:pathology*
Clin Obstet Gynecol. 1995 Sep;38(3):644-8
8612374
Obstet Gynecol Surv. 2005 May;60(5):315-20
15841025
J Low Genit Tract Dis. 2006 Jan;10(1):5-9
16378026
J Reprod Med. 2003 Jan;48(1):1-6
12611087
J Reprod Med. 2000 Apr;45(4):285-92
10804483
Obstet Gynecol. 2007 Aug;110(2 Pt 1):288-95
17666602
Obstet Gynecol. 2009 Jan;113(1):18-25
19104355
Obstet Gynecol. 2006 Aug;108(2):264-72
16880294
Clin Obstet Gynecol. 1995 Sep;38(3):649-52
8612375
Obstet Gynecol. 2000 Jun;95(6 Pt 1):801-3
10831970
J Reprod Med. 2004 Jan;49(1):1-7
14976787
Lancet Oncol. 2008 May;9(5):425-34
18407790
Obstet Gynecol. 2008 Dec;112(6):1419-1444
19037054
Am J Obstet Gynecol. 2004 Aug;191(2):430-4
15343217
Am J Obstet Gynecol. 2007 Oct;197(4):346-55
17904957
Cancer. 2006 Feb 25;108(1):32-8
16136595
Obstet Gynecol Clin North Am. 2008 Dec;35(4):583-97; viii
19061818
Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):372-9
12692113
J Obstet Gynaecol Can. 2006 Dec;28(12):1095-1098
17169233
Obstet Gynecol. 2010 Feb;115(2 Pt 1):243-248
20093895
Int J Gynecol Cancer. 1992 Sep;2(5):256-262
11576267